Maintenance Chemotherapy or Observation Following Induction Chemo and Radiation for Ependymoma
Full IRB Study Title:
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years
IRB Study ID: 1110813
For complete information, please visit the study on clinicaltrials.gov
Study Sponsor:
Children's Oncology Group
We are currently recruiting
If you are interested in this study or have questions about your child's eligibility, please contact:
Rebecca D. Considine Research Institute, 330-543-3193 or email research@akronchildrens.org